Evidence map›Paper›PMID 40970817›Full record

ArticleAging cell2025

An Unbiased Cell-Culture Selection Yields DNA Aptamers as Novel Senescent Cell-Specific Reagents.

Keenan S Pearson, Sarah K Jachim, Caroline D Doherty, Brandon A Wilbanks, Luis I Prieto, Maria Dugan, Darren J Baker, Nathan K LeBrasseur, L James Maher

Abstract read
In one paragraph

Article in Aging cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. NAR cancer · 2026
    Article
  2. Review
  3. Methods for cell- and tissue-specific DNA aptamer selection.Molecular therapy. Methods & clinical development · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Keenan S PearsonDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.ORCID 0000-0002-4504-4002
Sarah K JachimThe Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA.
Caroline D DohertyDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Brandon A WilbanksDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Luis I PrietoDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Maria DuganDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Darren J BakerDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Nathan K LeBrasseurThe Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-2002-0418
L James MaherDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.ORCID 0000-0002-5043-6422

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Lila J. Rutten · 1985 to 2026
$151.3M
Targeting Cellular Senescence to Extend HealthspanP01AG062413 · NIA · MAYO CLINIC ROCHESTER · PI Sundeep Khosla, Nathan K LeBrasseur · 2019 to 2026
$28.7M
Midwest Murine-Tissue Mapping Center (MM-TMC)U54AG079754 · NIA · UNIVERSITY OF MINNESOTA · PI GR Scott Budinger, Sundeep Khosla · 2022 to 2026
$11.5M
Biology of Aging and Age-Related Diseases Training GrantT32AG000213 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Rozalyn M. Anderson, Sanjay Asthana · 1991 to 2026
$9.9M
Musculoskeletal Research Training ProgramT32AR056950 · NIAMS · MAYO CLINIC ROCHESTER · PI Jennifer J Westendorf · 2009 to 2026
$7.0M
Glenn Foundation for Medical ResearchNCI NIH HHS P30 CA015083NIAMS NIH HHS T32 AR056950NIA NIH HHS P01 AG062413NIA NIH HHS T32 AG000213NIA NIH HHS U54 AG079754NIGMS NIH HHSNIH HHS AG000213NIH HHS AG062413NIH HHS AG079754NIH HHS AR056950NIH HHS GM139384
6 · The paper itself

Abstract

Cellular senescence is an irreversible form of cell-cycle arrest caused by excessive stress or damage. While various biomarkers of cellular senescence have been proposed, there are currently no universal, stand-alone indicators of this condition. The field largely relies on the combined detection of multiple biomarkers to differentiate senescent cells from non-senescent cells. Here we introduce a new approach: unbiased cell culture selections to identify senescent cell-specific folded DNA aptamers from vast libraries of trillions of random 80-mer DNAs. Senescent mouse adult fibroblasts and their non-senescent counterparts were employed for selection. We demonstrate aptamer specificity for senescent mouse cells in culture, identify a form of fibronectin as the molecular target of two selected aptamers, show increased aptamer staining in naturally aged mouse tissues, and demonstrate decreased aptamer staining when p16 expressing cells are removed in a transgenic INK-ATTAC mouse model. This work demonstrates the value of unbiased cell-based selections to identify new senescence-specific DNA reagents.

Indexed as

Aptamers, NucleotideCell Culture TechniquesCellular SenescenceAnimalsCells, CulturedCyclin-Dependent Kinase Inhibitor p16FibroblastsFibronectinsHumansMiceMice, TransgenicAptamers, NucleotideCyclin-Dependent Kinase Inhibitor p16Fibronectinsaptamerfibronectinin vitro selectionSELEXsenescence

Identifiers

PMID40970817
PMCPMC12610408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.